L3VLUP
ProSign in

STE in the 13F filings

Steris PLC · CUSIP G8473T100

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2024
the date the book describes
Filed
14 Feb 2025
latest of these filings; the earliest 12 Feb 2025
Managers listing it
7
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q3 2024 and Q4 2024; 5 listed it in both
Shares listed
6,842,650
combined, among listed positions
Reported value
$1.4bn
combined, at the quarter end

Among the 94 comparable managers: 2 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing STE in Q4 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

7 of 7 holders

ActionFiling
MFS Investment Management4,987,203$1.0bn0.32%Trimmed-1,348,30212 Feb 2025 (the filing on sec.gov)
Janus Henderson Group Ltd1,413,306$291m0.15%Trimmed-273,27614 Feb 2025 (the filing on sec.gov)
Marshall Wace LLP170,787$35munder 0.1%Trimmed-347,61513 Feb 2025 (the filing on sec.gov)
Two Sigma Investments LP160,778$33m0.07%Addedn.a.14 Feb 2025 (the filing on sec.gov)
GAMCO Investors Inc84,350$17m0.18%Trimmed-80013 Feb 2025 (the filing on sec.gov)
Holocene Advisors LP15,258$3.1munder 0.1%Newnew14 Feb 2025 (the filing on sec.gov)
Bridgewater Associates LP10,968$2.3munder 0.1%Trimmed-4,77313 Feb 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2024 to Q4 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
7 in Q3 2024 to 17 in Q2 2026

Tracked managers listing it, at least.

0510152020192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
STE by quarter
QuarterHoldersReported valueBuyersSellers
Q1 201910$1.8bnn.a.n.a.
Q2 20199$2.1bnn.a.n.a.
Q3 201914$1.7bnn.a.n.a.
Q4 201917$2.0bnn.a.n.a.
Q1 202016$1.5bnn.a.n.a.
Q2 202012$1.5bnn.a.n.a.
Q3 20209$1.8bnn.a.n.a.
Q4 202011$1.8bnn.a.n.a.
Q1 20219$1.8bnn.a.n.a.
Q2 202113$1.9bnn.a.n.a.
Q3 202111$2.0bnn.a.n.a.
Q4 20219$2.9bnn.a.n.a.
Q1 202210$3.3bnn.a.n.a.
Q2 202210$2.7bnn.a.n.a.
Q3 202211$2.0bnn.a.n.a.
Q4 20229$2.2bnn.a.n.a.
Q1 202310$2.5bnn.a.n.a.
Q2 202310$2.8bnn.a.n.a.
Q3 202312$2.6bnn.a.n.a.
Q4 20238$2.5bn45
Q1 20248$2.6bn16
Q2 20247$2.2bn34
Q3 20247$2.4bn25
Q4 20247$1.4bn25
Q1 20257$1.7bn52
Q2 202512$2.2bn74
Q3 20259$2.4bn63
Q4 202512$3.2bn2410
Q1 202613$3.4bn1817
Q2 202617$3.6bn2212

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

STE and LLY →STE and JNJ →STE and VRTX →Choose a stock to compare with STE →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own STE, latest filings →Back to the 13F Explorer →